Jump to ContentJump to Main Navigation
Evidence versus politicsExploiting research in UK drug policy making?$
Users without a subscription are not able to see the full content.

Mark Monaghan

Print publication date: 2011

Print ISBN-13: 9781847426970

Published to Policy Press Scholarship Online: March 2012

DOI: 10.1332/policypress/9781847426970.001.0001

Show Summary Details

Conclusion

Conclusion

Chapter:
(p.153) Nine Conclusion
Source:
Evidence versus politics
Author(s):

Mark Monaghan

Publisher:
Policy Press
DOI:10.1332/policypress/9781847426970.003.0009

This chapter closes the book with a discussion of what debates relating to evidence-based policy can tell drug policy makers, and likewise what lessons from drug policy making can be learnt by those advocating that all policies should be made with recourse to a robust evidence base. In doing so, it speculates on what the future may be for evidence-based policy. Even though the road ahead will continue to be perilous, the message is ultimately one of cautious optimism for the evidence movement. In contemporary society, evidence-based policies have become the benchmark by which most policies are judged. Debates in UK drug classification are indicative of this and have been the case study through which the turbulent nature of evidence has been explored in this book.

Keywords:   evidence-based policy, drug policy makers, evidence movement, UK drug classification

Policy Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.